https://staging-d.bts.org.uk/wp-content/uploads/2022/08/BTS_LOGO_WEB.png?_t=166143718400Site Content Teamhttps://staging-d.bts.org.uk/wp-content/uploads/2022/08/BTS_LOGO_WEB.png?_t=1661437184Site Content Team2023-11-21 09:52:502023-11-22 13:15:38BSHI AND BTS UK GUIDELINE ON THE DETECTION OF ALLOANTIBODIES IN SOLID ORGAN (AND ISLET) TRANSPLANTATION
https://staging-d.bts.org.uk/wp-content/uploads/2022/08/BTS_LOGO_WEB.png?_t=166143718400Site Content Teamhttps://staging-d.bts.org.uk/wp-content/uploads/2022/08/BTS_LOGO_WEB.png?_t=1661437184Site Content Team2023-08-01 09:50:362023-08-07 16:16:05UK GUIDELINES ON TRANSPLANTATION FROM DECEASED DONORS AFTER CIRCULATORY DEATH
https://staging-d.bts.org.uk/wp-content/uploads/2022/08/BTS_LOGO_WEB.png?_t=166143718400Site Content Teamhttps://staging-d.bts.org.uk/wp-content/uploads/2022/08/BTS_LOGO_WEB.png?_t=1661437184Site Content Team2023-06-16 08:38:522023-08-08 08:01:21UK GUIDELINE FOR THE MANAGEMENT OF THE PATIENT WITH A FAILING KIDNEY TRANSPLANT
https://staging-d.bts.org.uk/wp-content/uploads/2022/08/BTS_LOGO_WEB.png?_t=166143718400Site Content Teamhttps://staging-d.bts.org.uk/wp-content/uploads/2022/08/BTS_LOGO_WEB.png?_t=1661437184Site Content Team2022-07-05 13:49:172023-06-30 08:08:32UK GUIDELINE ON PREVENTION AND MANAGEMENT OF CYTOMEGALOVIRUS (CMV) INFECTION AND DISEASE FOLLOWING SOLID ORGAN TRANSPLANTATION
